Idarubicin Injection 5 mg/5 mL (5)

Država: Avstralija

Jezik: angleščina

Source: Department of Health (Therapeutic Goods Administration)

Aktivna sestavina:

idarubicin hydrochloride, Quantity: 1 mg/mL

Dostopno od:

Pfizer (Perth) Pty Ltd

Farmacevtska oblika:

Injection, solution

Sestava:

Excipient Ingredients: glycerol; hydrochloric acid; water for injections

Pot uporabe:

Intravenous

Enote v paketu:

1 X 5 mL

Tip zastaranja:

(S1) This Schedule is intentionally blank

Terapevtske indikacije:

Acute myeloid leukaemia in combination with other cytotoxic agents. Acute lymphoblastic leukaemia as a reserve medicinal product in combination with other cytotoxic agents.

Povzetek izdelek:

Visual Identification: Plastic vials containing a red-orange, clear, mobile solution; Container Type: Vial; Container Material: PP; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status dovoljenje:

Listed (Export Only)

Datum dovoljenje:

2023-03-03